Media Planner

Official Canadian Publication for Pharmaceutical & Biopharmaceutical Industry

Introduction

Since Pharmaceutical Canada's introduction in June 2000, it rapidly evolved to a "must-have and must-read" trusted source of information for our colleagues in Pharmaceutical and Biopharmaceutical industries.

All of us at Pharmaceutical Canada are committed to providing our subscribers with the most recent and truthful information available in order to assist the key decision makers having a better source of information when making purchasing assessment or acquiring services.

Pricing pressures, weak product pipelines, patent expiries and safety concerns are just some of the challenges driving change in the pharmaceutical industry's traditional ways. By feedback from our subscribers, industry experts including our editorial advisory board, and trade organizations we constantly work hard to have better content to meet and surpass the needs of the ever changing marketplace. In other word each issue of Pharmaceutical Canada is filled with thought provoking coverage of what our subscribers need to know.

Much of our success is due to industry experts who have kindly shared their time and knowledge.

Circulation department continues to stay on top of ongoing company and personnel changes at subscriber organizations. We also maintain a high profile at leading industry trade shows and exhibitions.

As you review our 2007 Media kit, you'll find out why the industry's most compelling read is also an effective Marketing tool for your company.

I encourage you to contact us directly with any questions or suggestions you may have about our publication and how we can better meet your specific requirements.

4.25

To reach our subscribers

Our efforts have made Pharmaceutical Canada the perfect choice for Pharmaceutical and Biopharmaceutical professionals. Pharmaceutical Canada has a circulation consisting of 10,000 mid-to-upper level managers and professionals working on all phases of R&D, Method development, Quality, Production as well as Packaging and labelling.

In addition to utilizing benchmark subscriber acquisition initiatives, we are also working to form several strategic relationships with associations, affinity groups, trade shows, and other applicable organizations to deliver Pharmaceutical Canada as an additional member benefit.

Our focused content attracts and delivers top industry professionals and we continue our circulation endeavour to ensure that advertisers reach decision makers with purchasing influence.

Pharmaceutical, Biotech and allied Industries, Contract Laboratories: Manufacturing, Research, Process Development, Consultants, Independent Analytical Labs/Contract Research

Academia - Universities, Research Institutes, Colleges

Architecture/Engineering/Construction/Validation

Government (Health Canada, FDA, etc.)

Industry Suppliers and Service Providers

Business / Investment / Legal Services

39.5%

Business/Industry

Job Function

Position Held

Managers

Director

Associates

Consultants

Analysts

Research & Development

Validation

Quality Assurance

Production and Manufacturing

Marketing & Sales Mgmt

Tech/Analytical Service/Support

Engineering

Information Technology

17%

82%

6%4.5%3.5%3%1%

1%1.5% 3.5%

12%

12.5%

13%

45%

21%

18.5%

10.5%

5%

Editorial Focus

Pharmaceutical Canada provides its readerships scientific, technical, management oriented non-biased "how to" articles with the goal to keep them informed about the latest developments in Pharmaceutical and Biopharmaceutical industries. Pharmaceutical Canada's news content covers a variety of events in the industry.

Our 2007 editorial topics includes:

• Industry's key issues• Laboratory • Validation • Life Sciences • Biotechnology -Biosimilars • Quality and Compliance • Dissolution • Manufacturing • Technology• CTD and eCTD• IT• Stability Testing • Packaging and labelling• Transportation and Material Handling • Outsourcing strategies • Regulatory Affairs• Excipients and Active Ingredients

For guidelines on submitting articles and news releases, contact editor@pharmaceuticalcanada.ca

$8600

$4900

$3700 $3500 $3400 $3100

$3700 $3500 $3400 $3100

$2700 $2550 $2350 $2100

$2700 $2550 $2350 $2100

$4650 $4450 $4150

$3100 $2850 $2650 $2450

$3100 $2850 $2650 $2450

$750 $700 $650 $600

$750 $700 $650 $600

$8300 $8000 $7800

2007 Advertising Rates& Digital File Specifications

1x 2x 3x 4x

Half Page AdFinal magazine size 4.25"W x 11"H (Vertical)Final magazine size 8.5"W x 5.5"H (Horizontal)

1/3 Page AdFinal magazine size 8.5"W x 3.7"H (Horizontal)Final magazine size 2.8"W x 11"H (Vertical)

8.5"W x 11"HTrim Size

8.0"W x 10.50"HText Safety

9.0"W x 11.50"HBleed size

4.25

2.80"W x 11.00"HTrim Size

2.30"W x 10.50"HText Safety

3.30"W x 11.50"HBleed size

8.5"W x 3.7"HTrim Size

8"W x 3.2"HText Safety

9"W x 4.2"HBleed size

1/4 Page AdFinal magazine size 4.25"W x 5.5"H

4.25"W x 5.5"HTrim Size

3.75"W x 5"HText Safety

4.75"W x 6"HBleed size

8.5"W x 5.5"HTrim Size9"W x 6"HBleed size8"W x 5"HText Safety

Full Page AdFinal magazine size 8.5"W x 11"H

4.25"W x 11"HTrim Size4.75"W x 11.5"HBleed size 3.75"W x 10.50"HText Safety

A d s to b e in e le c tr o n ic f o r m a t . S u p p ly C o lo r p r o o f s w ith a ll a d s

Options for artwork are:

- Quark Express 4.11 or earlier (Mac Format only)- Adobe Photoshop, CMYK (Mac/PC) - Adobe Illustrator, fonts to outlines (Mac/PC)- Hi-Res. EPS Files, CMYK (Mac/PC)- TIFF formats, CMYK and Min. 300 DPI (Mac/PC)* Please include fonts

P le a s e s u b m it y o u r a r tw o r ka n d p r o o fs to :

Attention: Rebecca Tan200 Consumers Road, Suite 610North York, OntarioCanada M2J 4R4

If y o u h a v e q u e s tio n s r e g a r d in gy o u r a r tw o r k p le a s e c a ll R e b e c c a T a n a t:

Tel: 416-410-7486Fax: 416-491-3428e-mail: rtan@pharmaceuticalcanada.cawww.pharmaceuticalcanada.com

Digital File Specifications

4.25

Sponsorship

The one and only publication covering Canadian Pharmaceutical and Biopharmaceutical Industry from R&D to market, from molecules to products, from ideas to realities. Pharmaceutical Canada doesn't give readers "jargon". We give in-depth analysis of:

It is a simple, effective and stimulating strategy to challenge the old way of thinking and foster the emergence of new thoughts. We have the pulse of the industry.

10 Good Reasons to Sponsor10 Good Reasons to SponsorConnect with real decision makers in the industry; specialists, scientists, managers, and executives.

Connect with the real users of your products and services.

Powerful industry presence and branding.

Quick, powerful business connections with colleagues and industry participants.

Increase exposure and sales channels.

Inform industry professional and opinion leaders of your resources and opportunities.

Your support help in promoting and uniting of the pharmaceutical companies, academia, and suppliers together.

Help create a stronger industry front.

Support an important contribution to the knowledge based economy of Canada.

Promote your products and services to the Canadian pharma and biopharma industry effectively.

Global and Canadian R&D developments and latest technologies and products available to the industry.

Latest manufacturing and sourcing processes affecting productivity and quality aspect of pharmaceutical industry.

Latest Global and Canadian regulatory changes and their effect on the industry.

Changes of pharmaceutical landscape, emergence of new class of pharmaceuticals, deal makers, adn deal breakers.

Canadian health care policies and its effect on the industry.

Our Team

Editorial Advisory Board

PUBLISHERDr. Mehrdad Barghian, President

EDITOR IN CHIEFDr. Yogesh Dandiker

MARKETING & SALESRay Taleghani, Director of Marketing & Business Development

GRAPHIC DESIGN & ART WORKRebecca Tan, Art Director

Andy Lee, Graphic Designer

CIRCULATION Robert Owen, Administration

CHIEF ACCOUNTANTCheung & Associate, Chartered Accountants

Laleh Bighash, COOAcademy of Applied Pharmaceutical Sciences

Dr. Nicholas F. Cappuccino, Executive Vice President, Cheif Scientific Officer and Chief Technical Officer Andrx Pharmaceuticals

Dr. Roshan Carpenter, Associate Director Regulatory Affairs GlaxoSmithKline Inc.

Sultan Ghani, Acting Director, Bureau of Pharmaceutical SciencesTPD- Health Canada

Dr. John C. Fanaras, PresidentNucro-Technics

Dr. Salim Farah, Associate Director, Quality AssuranceApotex

Dr. Helen Galat, Director of Manufacturing Improvements Sanofi Pasteur

Dr. Pavel Hadina, MD, Professor of Pharmacology, Department of Cellular and Molecular Medicine University of Ottawa

Dr. Syed Imtiaz Haider, Quality Affairs Director Julphar-Gulf Pharmaceutical Ind.

George Markus, Consultant

Dr. Mary Mazur-Melnyk, Consultant Innovalinks

Dr. Manny Papadimitropoulos, Associate Director, Clinical Research, OperationsEli Lilly Canada Inc.

Andrei Ponomarev, President AP-Pharma Compliance Associates (APPCA)

Dr. Saeed A. Qureshi, D.Sc., Senior Research Scientist, Research Laboratory Bureau of Pharmaceutical SciencesTPD- Health Canada

Dr. Arun V. Ravindran, MD, Professor of Psychiatry & Pharmacology, Scientific Director, Institute of Mental Health Research University of Ottawa

Dr. Ravi Tan, R&D ManagerCobalt Pharmaceutical Inc.

Ronald Turton, Chief Scientific OfficerQCL Quality Compliance Laboratories

David W. Vincent, CEO and COOValidation Technologies, Inc.

Dr. Aaron Wolkoff, PresidentWaters Canada

The Editorial Advisory Board of Pharmaceutical Canada is a distinguished group of specialists representing various facet of Canadian Pharmaceutical Industry and Academia. Member of the board review manuscripts and suggest subject matter pertinent to the profession. All manuscripts must first be submitted to the Editor, Pharmaceutical Canada: editor@pharmaceuticalcanada.ca.